Top 5 Companies of the Biomarker Technologies Market
Top 5 Companies of the Biomarker Technologies Market
Dec 29, 2021

Top 5 Companies of the Biomarker Technologies Market

Biomarker is basically a molecule that is found in the body fluid or tissues and blood, which indicates the normal and abnormal functions of the body. A biomarker is used in the entire drug discovery as well as the development process for understanding fundamental biological processes and their relationship. By utilizing different technologies, new biomarkers are discovered to unlock new decrease progression. As biomarkers have the capacity to diagnose various diseases at an initial stage, it is widely used to detect cancer and treat the disease.

These days biomarkers technologies market is making expansion owing to advancements in the field of discovery and technologies. In 2021, the global biomarker technologies market was valued at USD 32,600.71 million it is anticipated to grow at a CAGR of 11.3% during the forecast period, according to a new market study by Quince Market Insights. Various companies are witnessing huge growth in the biomarker technologies market. Here we have listed the top 10 companies operating in the global biomarker technologies market.

Thermo Fisher Scientific, Inc. (U.S.)

Based in Waltham, Massachusetts, United States, Thermo Fisher Scientific is basically an American provisionary of scientific instrumentations, consumables, reagents, and software services. The company has made a significant presence in the global biomarker technologies market. In July 2020, the company consented to partner symptomatic arrangements with Chugai Pharmaceutical to expand the use of the Oncomine Dx Target Test and facilitate nearby biomarker testing of non-little cell cellular breakdown in the lungs patients qualified for treatment in Japan. The company has also collaborated with Newomics, which is the main provider of microfluidics for fluid chromatography-mass spectrometry applications.

QIAGEN N.V. (Germany)

QIAGEN is based in Hilden Germany, which is engaged in providing sample and assay technologies for applied testing, molecular diagnostics, academic, as well as pharmaceutical research. The company has its branches in over 25 countries having 35 offices. As mentioned above the company is a global provider of molecular samples. Sample technology is used for collecting samples of tissues, fluid and blood and stabilizes, extracts, and purifies different molecules of interest like RNA, DNA, and proteins. In November 2020, the company collaborated with BioNTech for creating and market tissue-oriented buddy analytic which is to be used with investigational malignant growth treatment. This differentiates patients with human papillomavirus-related to squamous cell carcinoma. The company plans to make an expansion for use across HPV driven malignancies.

Agilent Technologies, Inc. (U.S.)

Based in California, Agilent Technologies Inc. is an American analytical instrumentation development as well as a manufacturing company. The company is engaged in offering its products and services to markets across the world. Agilent Technologies offers analytical instruments, services, software, and consumables for the laboratory workflow. In November 2020, the company introduced the biomarker pathologist training program. It is a global initiative that is designed to motivate pathologists to score biomarkers accurately.

Waters Corporation (U.S.)

Based in Milfort, Massachusetts, Waters Corporation is one of the leading providers of lab equipment, supplies, and software for scientists in various parts of the world. The company is mainly focused to improve human health and wellbeing through the application of high-end analytical technologies as well as industry-leading scientific expertise. In July 2021, the company has recently collaborated with Singapore’s Bioprocessing Technology Institute to help accelerate biologics production through research collaboration.

Danaher Corporation (U.S.)

Danaher Corporation is based in Washington and is listed under the Fortune 500 science and technology innovator which helps in solving complex challenges and improves the quality of life across the world. The company is engaged in designing, manufacturing, and marketing professional, medical, commercial, and industrial products as well as services. Danaher Corporation develops innovative tools leading-edge diagnostic tools, advances the life-saving. scientific research and protects the food and water supplies across the globe.

The increasing research and development in the healthcare industry, increasing trend of biomarkers in the past few years, significant growth of biomarkers to treat different types of cancers as well as increasing clinical trials for the biomarkers are driving the biomarkers technologies market. Not only this but also the development of the healthcare infrastructure in the developing countries and favorable reimbursement scenarios are increasing the demand of the global biomarker technologies market. In addition, the increasing geriatric population in the globe along with the rising disposable income of the people demanding quality healthcare facilities is accelerating the overall growth of the global biomarker technologies market.

For more information, please check the latest study on global biomarker technologies market

Check our website 

You can also contact us at -


Leave a Reply